Skip to main content
. 2022 Jan 17;9(2):ofab644. doi: 10.1093/ofid/ofab644

Figure 2.

Figure 2.

Odds ratios of mortality for levofloxacin vs trimethoprim-sulfamethoxazole targeted therapy among primary cohort and subpopulations of interest. Forest plot of boxes depicting adjusted odds ratio with 95% confidence intervals shown as horizontal lines. ∗Excluding drugs with known activity against S maltophilia other than Trimethoprim-sulfamethoxazole and Levofloxacin (Appendix Table 4). †Unadjusted data calculated using Fisher\'s exact test. ‡Adjusted values were calculated using logistic regression after controlling for baseline patient and hospital level factors. Clinically relevant sub-populations were also analyzed for potential disparate impacts on mortality. Abbreviations: CI, confidence interval; OR, odds ratio; SOFA, Sequential Organ Failure Assessment; TMP-SMX, trimethoprim-sulfamethoxazole.